Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
84.52
+1.10 (1.32%)
At close: Oct 2, 2026, 4:00 PM EDT
84.49
-0.03 (-0.04%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $5.6 billion as of October 2, 2026. Its market cap has increased by 521.15% in one year.
Market Cap
5.60B
Enterprise Value
4.47B
1-Year Change
521.15%
Ranking
Category
Stock Price
$84.52
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $5.60B, an increase of 558.88%. That is a compound annual growth rate of 146.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 5.60B | 281.39% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.04B |
| CG Oncology | 5.97B |
| Kodiak Sciences | 5.92B |
| Scholar Rock Holding | 5.70B |
| Mirum Pharmaceuticals | 5.38B |
| Cogent Biosciences | 5.38B |
| Travere Therapeutics | 5.37B |
| CRISPR Therapeutics AG | 5.36B |